Tradestie Institutional Equity Comparison Engine

MAIA vs SILO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MAIA Overall Edge

MAIA Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MAIA Biotechnology, Inc. (MAIA) driven by superior Valuation, Growth & Margin while SILO counters with relative strength in Momentum & Technical. Fundamentally, MAIA trades at 1.2x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SILO at N/M Forward P/E and -8250.5% operating margin (+0.0% YoY). In options structure, MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SILO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MAIA
MAIA 1.2x vs SILO N/M Fwd P/E
Growth & Margin Winner MAIA
Op Margin 0.0% vs -8250.5% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner SILO
1Y +20.6% vs +332.9% ยท 52W Pos 10% vs 19%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
MAIA NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
1M Return -1.77%
1Y Return +20.65%
Forward P/E 1.2x
Unified AI Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0
SILO NASDAQ
Silo Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.71
-9.04% 1D
Market Cap $4.1M
1M Return +44.92%
1Y Return +332.91%
Forward P/E N/M
Unified AI Score
29.9 / 100 SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: MAIA +20.65% SILO +332.91% Spread: +312.26 pp (SILO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
MAIA TTM Op. Margin: 0.0% SILO TTM Op. Margin: -8250.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on MAIA vs SILO. Trailing 12-month operating profitability (MAIA 0.0% vs SILO -8250.5%) and valuation multiples (MAIA 1.2x vs SILO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: MAIA (6) vs SILO (2)
Institutional Metric MAIA SILO Criterion Row Winner
Market Capitalization Scale $68.5M $4.1M Larger Scale MAIA
Trailing P/E Ratio Valuation 1.2x N/M Lower Multiple MAIA
Forward P/E Ratio Valuation 1.2x N/M Lower Multiple MAIA
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability 0.0% -8250.5% Higher Margin MAIA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -341.5% -91.2% Higher ROE SILO
52-Week Range Position Momentum 10% ($1โ€“$3) 19% ($0โ€“$8) Stronger Trend SILO
Beta / 30D Volatility Risk Regime 1.65ฮฒ ยท 108% Vol -6.73ฮฒ ยท 123% Vol Lower Realized Risk MAIA
Unified Institutional Score Composite Signal 37.6 / 100 (SELL) 29.9 / 100 (SELL) Higher Composite MAIA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full MAIA vs SILO Buy Guide
MAIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MAIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SILO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SILO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither MAIA nor SILO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.